# Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

> **NCT03987217** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 73 (actual)

## Conditions studied

- Fatigue
- Metastatic Prostate Carcinoma
- Sedentary Lifestyle
- Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8
- Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8
- Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8

## Interventions

- **DIETARY_SUPPLEMENT:** Creatine Monohydrate
- **BEHAVIORAL:** Exercise Intervention
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT03987217
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-17
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-03-10
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987217, "Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03987217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*